Shopping Cart 0
Cart Subtotal
USD 0

Cesca Therapeutics Inc (KOOL) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Cesca Therapeutics Inc (Cesca) researches, develops, and commercializes cell based therapeutics for applications in regenerative medicine. Its proprietary technology platform, PXP is used to develop autologous cell-based therapies for the in the vascular and orthopedic markets. Its device division, ThermoGenesis Corp. offers the AutoXpress platform for automated clinical biobanking. The company is also developing CAR-TXpress platform for bio-manufacturing which find applications in immuno-oncology therapeutics. The company markets its products to patients, physician and partners in three target markets, namely, cellular therapeutics, medical/diagnostic device development and commercialization, and cell manufacturing and banking. Cesca is headquartered in Rancho Cordova, California, the US.

Cesca Therapeutics Inc (KOOL)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Cesca Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Cesca Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 8

Cesca Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Cesca Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 10

Cesca Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

Cesca Therapeutics Inc, Medical Equipment, Deal Details 13

Asset Purchase 13

Cesca Therapeutics Acquires Cell Processing Systems of SynGen 13

Venture Financing 14

SynGen Raises USD0.4 Million in Venture Financing 14

SynGen Raises USD0.5 Million in Venture Financing 15

SynGen Raises USD0.5 Million in Venture Financing 16

SynGen Raises USD1 Million in Venture Financing 17

SynGen Raises USD1 Million in Venture Financing 18

SynGen Raises USD1.5 Million in Financing 19

SynGen Raises USD2 Million in Financing Round 20

SynGen Raises USD2.25 Million in Venture Financing 21

SynGen Raises USD5 Million in Extended Series A Venture Financing 22

SynGen Raises USD2 Million in Venture Financing 23

SynGen to Raise Funds in Financing 24

SynGen To Raise Funds Through Venture Financing Round 25

SynGen Raises USD 1 Million In Venture Financing 26

SynGen Raises USD 5 Million In Series A Financing 27

Partnerships 28

Cesca Therapeutics Enters into Distribution Agreement with Boyalife 28

Texas Stem Cell Enters into Agreement with Cesca Therapeutics 29

Cesca Therapeutics Enters into Distribution Agreement with Miltenyi Biotec 30

ThermoGenesis Enters Into Co-Marketing Agreement With Golden Meditech Holdings 31

Thermogenesis Enters Into Distribution Agreement With Arthrex For Res-Q System 32

Merger 33

TotipotentRx Completes Merger With ThermoGenesis 33

IncoCell Tianjin Enters into Licensing Agreement with Cesca Therapeutics 35

Equity Offering 36

Cesca Therapeutics Plans to Raise Funds through Public Offering of Shares 36

Cesca Therapeutics Raises USD5.5 Million in Public Offering of Units 37

Cesca Therapeutics to Raise USD1.4 Million in Private Placement of Shares 38

Cesca Therapeutics to Raise USD15 Million in Public Offering of Shares 39

Cesca Therapeutics Prices Public Offering of Shares for USD2.7 Million 40

Cesca Therapeutics Prices Private Placement of Shares for USD2.5 Million 41

Cesca Therapeutics to Raise USD2.5 Million in Private Placement of Shares 42

Cesca Therapeutics Raises USD11.3 Million in Public Offering of Units 43

ThermoGenesis Completes Private Placement Of Common Stock And Warrants For USD 6.7 Million 45

Debt Offering 46

Cesca Therapeutics to Raise USD12.5 Million in Private Placement of 22% Debentures Due 2019 46

Cesca Therapeutics Raises USD5.5 Million in First Tranche of Private Placement of Debentures Due 2045 47

Asset Transactions 48

Cesca Therapeutics Acquires Cell Processing Systems of SynGen 48

Helmer Acquires Thermoline Plasma Freezer And Thawer Product Line Of Thermogenesis 49

Asahi Kasei Completes Acquisition Of CryoSeal FS System From ThermoGenesis For USD 2 Million 50

Cesca Therapeutics Inc-Key Competitors 52

Cesca Therapeutics Inc-Key Employees 53

Cesca Therapeutics Inc-Locations And Subsidiaries 54

Head Office 54

Other Locations & Subsidiaries 54

Recent Developments 55

Financial Announcements 55

Aug 13, 2018: Cesca Therapeutics announces second quarter 2018 financial results and provides corporate update 55

May 14, 2018: Cesca Therapeutics Reports First Quarter 2018 Financial Results 57

Mar 22, 2018: Cesca Therapeutics Announces Financial Results for the Transition Period July 1, 2017 to December 31, 2017, and Provides Corporate Update 58

Nov 14, 2017: Cesca Therapeutics Announces Financial Results for the Three Months Ended September 30, 2017 and Provides Corporate Update 60

Sep 19, 2017: Cesca Therapeutics Announces Fiscal Year 2017 Financial and Operating Results and Provides Corporate Update 62

May 11, 2017: Cesca Therapeutics Announces Fiscal Third Quarter and Nine Month 2017 Financial and Operating Results and Provides Corporate Update 63

Feb 13, 2017: Cesca Therapeutics Reports Second Quarter Fiscal 2017 Financial Results and Provides Business Update 65

Corporate Communications 66

Jun 04, 2018: Cesca Therapeutics Announces Reduction in Operating Expenses 66

Nov 22, 2017: Cesca Therapeutics Appoints Healthcare Investment Banking Veteran Joe E. Balagot as Senior Vice President of Corporate Development 67

Apr 03, 2017: Cesca Therapeutics Announces Senior Management Promotions 68

Feb 28, 2017: Cesca Therapeutics Strengthens Leadership Team and Board of Directors 69

Jan 17, 2017: Cesca Therapeutics Appoints Dr. Joseph Thomis to Its Board of Directors 70

Product News 71

Aug 29, 2018: Cesca Therapeutics announces poster presentation at the 4th annual CAR-TCR Summit 71

May 04, 2018: Cesca Therapeutics Presents New Data on its Proprietary X-Series Cellular Processing Systems 72

Apr 03, 2018: Cesca Therapeutics Announces Release of X-Mini Cell Selection Kit for the CAR-T Research Market 73

Mar 28, 2018: Cesca Therapeutics Announces Two Abstracts Accepted for Poster Presentation at the International Society for Cellular Therapy (ISCT) 2018 Annual Meeting 74

Nov 28, 2017: Cesca Therapeutics Announces Issuance of Second Cellular Processing Patent 75

Mar 20, 2017: Cesca CLI Feasibility Study Published in Peer-Reviewed Journal 76

Other Significant Developments 77

Sep 05, 2018: Cesca Therapeutics provides commercialization update for its X-Series product line 77

Apr 24, 2018: Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina Lineberger Advanced Cellular Therapeutics Facility for X-Series Products 80

Apr 17, 2018: Cesca Therapeutics Announces First Evaluation Agreement With a Leading U.S. Academic Research Institution for X-Series Products That Provide Automated, Closed System Cellular Processing 81

Aug 24, 2017: Cesca Therapeutics Announces International Distribution Agreement With Boyalife WSN 82

Appendix 83

Methodology 83

About GlobalData 83

Contact Us 83

Disclaimer 83


List Of Figure

List of Figures

Cesca Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Cesca Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Cesca Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Cesca Therapeutics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Cesca Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Cesca Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 8

Cesca Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Cesca Therapeutics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 10


List Of Table

List of Tables

Cesca Therapeutics Inc, Medical Equipment, Key Facts, 2017 2

Cesca Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Cesca Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 7

Cesca Therapeutics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 8

Cesca Therapeutics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 9

Cesca Therapeutics Inc, Deals By Market, 2012 to YTD 2018 10

Cesca Therapeutics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 11

Cesca Therapeutics Acquires Cell Processing Systems of SynGen 13

SynGen Raises USD0.4 Million in Venture Financing 14

SynGen Raises USD0.5 Million in Venture Financing 15

SynGen Raises USD0.5 Million in Venture Financing 16

SynGen Raises USD1 Million in Venture Financing 17

SynGen Raises USD1 Million in Venture Financing 18

SynGen Raises USD1.5 Million in Financing 19

SynGen Raises USD2 Million in Financing Round 20

SynGen Raises USD2.25 Million in Venture Financing 21

SynGen Raises USD5 Million in Extended Series A Venture Financing 22

SynGen Raises USD2 Million in Venture Financing 23

SynGen to Raise Funds in Financing 24

SynGen To Raise Funds Through Venture Financing Round 25

SynGen Raises USD 1 Million In Venture Financing 26

SynGen Raises USD 5 Million In Series A Financing 27

Cesca Therapeutics Enters into Distribution Agreement with Boyalife 28

Texas Stem Cell Enters into Agreement with Cesca Therapeutics 29

Cesca Therapeutics Enters into Distribution Agreement with Miltenyi Biotec 30

ThermoGenesis Enters Into Co-Marketing Agreement With Golden Meditech Holdings 31

Thermogenesis Enters Into Distribution Agreement With Arthrex For Res-Q System 32

TotipotentRx Completes Merger With ThermoGenesis 33

IncoCell Tianjin Enters into Licensing Agreement with Cesca Therapeutics 35

Cesca Therapeutics Plans to Raise Funds through Public Offering of Shares 36

Cesca Therapeutics Raises USD5.5 Million in Public Offering of Units 37

Cesca Therapeutics to Raise USD1.4 Million in Private Placement of Shares 38

Cesca Therapeutics to Raise USD15 Million in Public Offering of Shares 39

Cesca Therapeutics Prices Public Offering of Shares for USD2.7 Million 40

Cesca Therapeutics Prices Private Placement of Shares for USD2.5 Million 41

Cesca Therapeutics to Raise USD2.5 Million in Private Placement of Shares 42

Cesca Therapeutics Raises USD11.3 Million in Public Offering of Units 43

ThermoGenesis Completes Private Placement Of Common Stock And Warrants For USD 6.7 Million 45

Cesca Therapeutics to Raise USD12.5 Million in Private Placement of 22% Debentures Due 2019 46

Cesca Therapeutics Raises USD5.5 Million in First Tranche of Private Placement of Debentures Due 2045 47

Cesca Therapeutics Acquires Cell Processing Systems of SynGen 48

Helmer Acquires Thermoline Plasma Freezer And Thawer Product Line Of Thermogenesis 49

Asahi Kasei Completes Acquisition Of CryoSeal FS System From ThermoGenesis For USD 2 Million 50

Cesca Therapeutics Inc, Key Competitors 52

Cesca Therapeutics Inc, Key Employees 53

Cesca Therapeutics Inc, Other Locations 54

Cesca Therapeutics Inc, Subsidiaries 54

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Cesca Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.